Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rhoda B. Schleicher"'
Publikováno v:
Nutrition Research. 20:1279-1286
Iron bound to heme appears to be more bioavailable than iron salts, but in the United States no heme iron supplement presently exists. We performed iron absorption studies to evaluate a heme iron product made from digested hemoglobin (HIP) and compar
Autor:
Rhoda B. Schleicher, Jeffrey R. Parrish, Craig T. Jordan, Shanshan Pei, Paul A. Seligman, Prakhar Singal
Publikováno v:
Blood. 126:4975-4975
Iron is mainly used in oxygen transfer reactions including reactions necessary for cellular proliferation. Since iron is essential for cellular processes, but excess iron is toxic, complex pathways have evolved to maintain iron homeostasis in various
Publikováno v:
Blood. 82:1608-1617
Agents that interfere with cellular iron (Fe) incorporation inhibit tumor cell proliferation, including metals that bind to transferrin (Tf) such as gallium (Ga) or indium (In) and Fe chelators such as desferrioxamine (DFO). Ga nitrate is effective i
Publikováno v:
Blood. 78:1526-1531
Raji, a malignant B-lymphocyte cell line containing Epstein-Barr virus genomic elements, has been conditioned to proliferate optimally in transferrin (Tf)-free medium containing a very low concentration of an iron salt. We provide evidence that an Tf
Autor:
Jeni L Marks, Kelly E Capocelli, Meenakshi Singh, Christina Finlayson, Rhoda B. Schleicher, Paul A. Seligman
Publikováno v:
Applied immunohistochemistrymolecular morphology : AIMM. 13(2)
Neoadjuvant chemotherapy (NACT) has become the standard of care for patients with locally advanced breast cancer (LABC). This was a retrospective review of 21 consecutive women who received NACT as initial treatment of LABC, followed by surgical exci
Autor:
Jur Strobos, Michael A Jones, Rhoda B. Schleicher, Murray P. Ducharme, Paul A. Seligman, Naomi V. Dahl, Hui C Kimko
Publikováno v:
Pharmacotherapy. 24(5)
Study Objectives. To determine the single-dose pharmacokinetics of intravenous sodium ferric gluconate complex in sucrose injection (SFGC) in iron-deficient human volunteers, and to assess iron transport. Design. Open-label, randomized study. Setting
Autor:
Paul A. Seligman, Sana Ghaddar, Jeffrey S. Berns, Rhoda B. Schleicher, Allen R. Nissenson, Paul G. Sakiewicz, Gary M Moore
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 42(2)
Background: Optimizing iron and recombinant human erythropoietin (rHuEPO) therapy is necessary to achieve target hemoglobin levels and minimize costs as the end-stage renal disease (ESRD) population expands. Oral iron products in patients with ESRD h
Publikováno v:
American Journal of Hematology; 1992, Vol. 41 Issue 4, p232-240, 9p